Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
The Journal of General Virology
|
December 1, 1987
Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization
L Banks, G Matlashewski, D Pim, et al.
The Journal of General Virology
|
September 1, 1986
The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies
G Matlashewski, L Banks, J Wu-Liao, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health
|
November 26, 1999
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group
E Franco, L Villa, T Rohan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2005
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru
C Miranda-Verástegui, A Llanos-Cuentas, I Arévalo, et al.
The Journal of Biological Chemistry
|
August 29, 1998
Inducible expression of suicide genes in Leishmania donovani amastigotes
E Ghedin, H Charest, W W Zhang, et al.
The Journal of General Virology
|
May 1, 1987
Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas
L Banks, P Spence, E Androphy, et al.
Clinical and Diagnostic Laboratory Immunology
|
September 25, 1997
Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis
E Ghedin, W W Zhang, H Charest, et al.
Antimicrobial Agents and Chemotherapy
|
October 16, 2001
Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele)
J Moisan, W Wojciechowski, C Guilbault, et al.
International Journal of Cancer
|
August 5, 2000
P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation
H Makni, E L Franco, J Kaiano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2001
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
I Arevalo, B Ward, R Miller, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
The Journal of General Virology
|
December 1, 1987
Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization
L Banks, G Matlashewski, D Pim, et al.
The Journal of General Virology
|
September 1, 1986
The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies
G Matlashewski, L Banks, J Wu-Liao, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health
|
November 26, 1999
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group
E Franco, L Villa, T Rohan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2005
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru
C Miranda-Verástegui, A Llanos-Cuentas, I Arévalo, et al.
The Journal of Biological Chemistry
|
August 29, 1998
Inducible expression of suicide genes in Leishmania donovani amastigotes
E Ghedin, H Charest, W W Zhang, et al.
The Journal of General Virology
|
May 1, 1987
Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas
L Banks, P Spence, E Androphy, et al.
Clinical and Diagnostic Laboratory Immunology
|
September 25, 1997
Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis
E Ghedin, W W Zhang, H Charest, et al.
Antimicrobial Agents and Chemotherapy
|
October 16, 2001
Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele)
J Moisan, W Wojciechowski, C Guilbault, et al.
International Journal of Cancer
|
August 5, 2000
P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation
H Makni, E L Franco, J Kaiano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2001
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
I Arevalo, B Ward, R Miller, et al.
Page
of 6